We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Insiders in Amgen didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by ...

Amgen Inc's robust product portfolio and pipeline fortify its market position. Strategic acquisitions like Horizon Therapeutics enhance Amgen's therapeutic reach. Patent litigations and market ...

On Monday, Amgen Inc (AMGN) stock saw a decline, ending the day at $316.91 which represents a decrease of $-2.31 or -0.72% from the prior close of $319.22. The stock opened at $320.58 and touched a ...

Amgen Inc ( (AMGN) ) has realeased its Q3 earnings. Here is a breakdown of the information Amgen Inc presented to its investors. Amgen Inc., a ...

Amgen Inc (AMGN) reports a 23% revenue increase, driven by strong product sales and promising developments in its innovative ...

Amgen Inc. (AMGN) reported earnings for its third quarter that increased from the same period last year and beat the Street ...

Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ETCompany ParticipantsJustin Claeys - VP, IRRobert Bradway - ...

Shares of Amgen Inc. AMGN inched 0.78% higher to $321.79 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.53% to ...

On Tuesday, Amgen Inc (AMGN) stock saw a decline, ending the day at $316 which represents a decrease of $-1.17 or -0.37% from the prior close of $317.17. The stock opened at $317.01 and touched a low ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharma stocks. Healthcare takes the concept of ‘defensive’ further than almost any ...

Discover how Amgen is achieving a fully automated enterprise through strategic partnerships with Cognizant and UiPath to enhance efficiency.